Cours Sigyn Therapeutics, Inc. Other OTC
Actions
SIGY
US82674U1060
Equipement, fournitures et distribution médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 6,08 M 5,46 M |
---|---|---|---|---|---|
Résultat net 2022 | -2 M -1,8 M | Résultat net 2023 | -4 M -3,59 M | VE / CA 2022 | - |
Dette nette 2022 | 1,87 M 1,68 M | Dette nette 2023 | 2,47 M 2,22 M | VE / CA 2023 | - |
PER 2022 |
-2,13
x | PER 2023 |
-1,25
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 46,41% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Roberts
FOU | Founder | 71 | 19/10/19 |
James Joyce
CEO | Chief Executive Officer | 62 | 19/10/19 |
Jerry DeCiccio
DFI | Director of Finance/CFO | 67 | 12/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
James Joyce
CEO | Chief Executive Officer | 62 | 19/10/19 |
James W. Dorst
BRD | Director/Board Member | 69 | 10/10/22 |
Richa Nand
BRD | Director/Board Member | 50 | 10/10/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
-5,60% | 181 Md | |
-4,45% | 101 Md | |
-4,15% | 67,54 Md | |
-8,63% | 45,09 Md | |
+9,70% | 44,37 Md | |
+6,13% | 40,7 Md | |
+15,22% | 29,85 Md | |
+14,80% | 24,49 Md | |
-6,46% | 23,99 Md |